WCK 5222 is the first New Chemical Entity (NCE) discovered and developed in India to be submitted for pan-European marketing authorisation
Using a combination of blood and faecal samples, the service examines key biomarkers, including hereditary genetic status
The initiative is focused on a problem that continues to plague cancer outcomes in India
The ChemiSphere app exemplifies how M-Trust technology transforms workflows into seamless digital experiences
LNK01006 is designed to deliver potent, selective inhibition of TYK2-mediated cytokine signaling with central nervous system exposure
The Complement Laboratory is equipped with state-of-the-art immunoturbidimetric and ELISA platforms and adheres to CAP and NABL accreditation standards
HER2-mutant NSCLC typically has a poor prognosis and limited treatment options
Subscribe To Our Newsletter & Stay Updated